<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03316287</url>
  </required_header>
  <id_info>
    <org_study_id>17/0064</org_study_id>
    <nct_id>NCT03316287</nct_id>
  </id_info>
  <brief_title>Big Data Supporting Public Health Hearing Policies</brief_title>
  <acronym>EVOTION</acronym>
  <official_title>EVidenced Based Management of Hearing Impairments: Public Health pÎŸlicy Making Based on Fusing Big Data Analytics and simulaTION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hearing Loss (HL) affects over 5% of the world's population (WHO 2014) and is the 5th leading&#xD;
      cause of Years Lived with Disability. HL is currently managed with Hearing Aids (HAs), i.e.&#xD;
      programmable sound amplification devices that are worn by the hearing impaired subjects to&#xD;
      address their hearing difficulties. HA use however is often problematic, costly and with poor&#xD;
      overall benefits. The holistic management of HL requires appropriate public health policies&#xD;
      for HL prevention, early diagnosis, long-term treatment and rehabilitation; detection and&#xD;
      prevention of cognitive decline; and socioeconomic inclusion of HL patients. Currently the&#xD;
      evidential basis for forming such policies is limited.&#xD;
&#xD;
      The EVOTION project proposes to address this by collecting and analysing a big set of&#xD;
      heterogeneous data, including HA usage, audiological, physiological, cognitive, clinical and&#xD;
      medication, personal, behavioural, life style, occupational and environmental data.&#xD;
&#xD;
      This will be done by:&#xD;
&#xD;
      i. accessing big datasets of existing HA user data from the EVOTION clinical partners&#xD;
      (UCL/UCLH and GST in the UK; OTICON in Denmark) ii. collection of prospective HA user data&#xD;
      who will be recruited to the prospective EVOTION study and who will undergo some additional&#xD;
      assessments iii. collection of real time dynamic data of the human participant HA users who&#xD;
      will be given a smart phone with different apps (auditory tests; auditory training), sensors&#xD;
      (recording of heart rate, blood pressure, respiratory rate etc.) and smart HAs (recording&#xD;
      environmental factors such as noise levels, type of noise etc.) so that real life contextual&#xD;
      factors that affect HA usage and outcome can be identified.&#xD;
&#xD;
      These data will be analysed with big data analysis/data mining techniques in order to&#xD;
      identify relationships between these in order to use this information to derive and support&#xD;
      public health decisions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in &quot;Glasgow Hearing Aid Benefit Profile&quot; at 8 weeks</measure>
    <time_frame>Baseline (i.e. before the patient receives a hearing-aid) and at 8 weeks after receiving a hearing-aid</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1080</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Hearing aid + mobile phone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hearing aid + mobile phone + biosensor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hearing aid</intervention_name>
    <description>Smart hearing aid to allow collection of real time hearing aid usage data</description>
    <arm_group_label>Hearing aid + mobile phone</arm_group_label>
    <arm_group_label>Hearing aid + mobile phone + biosensor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mobile phone</intervention_name>
    <description>Mobile phone linked with the hearing aids to allow users to change the device settings and perform additional listening tests</description>
    <arm_group_label>Hearing aid + mobile phone</arm_group_label>
    <arm_group_label>Hearing aid + mobile phone + biosensor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sensor</intervention_name>
    <description>Wearable biosensor for the collection of physiological data</description>
    <arm_group_label>Hearing aid + mobile phone + biosensor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  Basic understanding of oral and written English&#xD;
&#xD;
          -  Unilateral and/or bilateral mild to severe sensorineural hearing loss&#xD;
&#xD;
          -  Willing to use smart hearing aids for at least 2 hours daily on average&#xD;
&#xD;
          -  Willing/capable to use a mobile phone&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dementia (MoCA&lt;22 )&#xD;
&#xD;
          -  Not agreeing or able to attend for f/u appointments&#xD;
&#xD;
          -  Not agreeing or able to use HA &gt;2 hours daily (average)&#xD;
&#xD;
          -  Not sufficient vision to use smartphone ap&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Guy's and St. Thomas' Foundation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 10, 2017</study_first_submitted>
  <study_first_submitted_qc>October 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2017</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

